Save the date

Truveta Symposium 2026

April 27 - 29 | Seattle, WA

Healthcare, public health, and life sciences Saving Lives with Data together

Come join us in Seattle

Please fill out the form below to attend Truveta Symposium.

If you have questions or need assistance, email us at symposium@truveta.com

Terms & conditions

By attending, you consent to being photographed and recorded by Truveta for marketing purposes. Personal recording or sharing is prohibited unless authorized, and we ask all participants to remain respectful and professional.

Close

Truveta Symposium uniquely brings together leaders from health systems, life sciences, and the government to collaborate on health research with real-world data, embracing generative AI to transform healthcare, and improving patient care and outcomes for all.

Agenda

Monday, April 27

Opening reception and innovation preview

PACCAR Pavillion
5:30 – 8:00 pm

Kick off Truveta Symposium 2026 with Truveta leaders and fellow attendees at the official opening of the symposium.
Be the first to preview new innovations, research, and collaborations that will shape the next two days.
Enjoy hosted appetizers, drinks, and live demos of the latest from Truveta.

Tuesday, April 28

Day 1

Bell Harbor Conference Center

8:00-9:00 am: Breakfast
9:00-10:30 am: Mainstage presentations
10:30-11:00 am: Coffee, connection, and curiosity
11:00 am-12:15 pm: Mainstage presentations
12:15-1:00 pm: Lunch, learn, and connect
1:00-1:30 pm: Mainstage presentations
1:30-3:00 pm: Technology keynotes & breakout sessions
3:00-3:30 pm: Coffee, connection, and curiosity
3:30-4:15 pm: Mainstage presentations
4:15-8:00 pm: Data, dialogue, and dinner

Wednesday, April 29

Day 2

Bell Harbor Conference Center

8:00-9:00 am: Breakfast
9:00-10:15 am: Mainstage presentations
10:15-10:45 am: Coffee, connection, and curiosity
10:45 am-12:00 pm: Mainstage presentations and closing remarks
12:00-1:00 pm: Lunch, learn, and connect
1:00-3:00 pm:. Breakout sessions

Conference sessions

Tuesday, April 28: Day 1

Mainstage presentations

Vision keynote: Saving Lives with Data: Intelligent evidence arriving in time	Terry Myerson, CEO and co-founder, Truveta
AI keynote: The revolution in healthcare	Jonathan Carlson, Vice President and Managing Director, Microsoft Health Futures
Product keynote: The roadmap for intelligent evidence	Michael Simonov, MD, Senior Vice President of Product, Truveta
Panel: Real-world evidence in action: Perspectives from life sciences leadership	Ryan Ahern, MD, MPH, Chief Medical Officer and co-founder, Truveta Michael R. Jaff, DO, Chief Medical Officer, Vice President, Clinical Affairs, Technology & Innovation, Peripheral Interventions, Boston Scientific Jen Webster, MS, Vice President, RWD Activation, Pfizer
Case studies: Real-world evidence advancing patient care	Khaled Abdelgawward, Senior Director and Principal RWE Researcher, Bayer Heather Rubino, PhD, MS, Head of Safety Surveillance, Pfizer
Panel: Health systems and life sciences partnering to advance evidence and care	Greg Gillum, RN, Director, Medical Affairs Impact and Data Enablement, Boehringer Ingelheim Pharmaceuticals, Inc. Jonathan Kolstad, PhD, Co-founder & CEO, Knit Health

Technology keynotes & breakout sessions

Technology keynotes: Exploring Truveta’s regulatory-grade, real-time technology foundation

Architecting a platform built to last	Jay Nanduri, Chief Technology Officer & co-founder, Truveta
Security and privacy at the core	Oscar Papel, Chief Information Security Officer, Truveta
Trusted AI inside	Anand Oka, Senior Vice President, AI, Truveta

Case studies: Advancing public health

Tracking uptake and adherence of emerging therapies: Lecanemab and oral semaglutide	Brianna Cartwright, MS, Senior Research Analyst, Truveta Research
Heat exposure and emergency department utilization	Amruta Nori-Sarma, PhD, MPH, Assistant Professor, Harvard T.H. Chan School of Public health and Deputy Director, Harvard C-CHANGE
Impact of clinical guidelines on patient care and outcomes	Nina Masters, PhD, Senior Applied Research Scientist, Truveta Research

Wednesday, April 29: Day 2

Mainstage presentations

Panel: From two trials to intelligent evidence: The new FDA approval standard

John Seegar, PharmD, DrPH, FISPE, SVP of Evidence Services, Truveta; former VP for Epidemiology for RTI-HS and Chief Scientific Officer for Epidemiology at Optum
Tracy Mayne, Senior Vice President, Regulatory & Life Sciences Research, SlipStream
Alessandro Albuquerque, MS MSc PhD, Chief Medical Officer and Vice President of Medical Affairs & Clinical Development, Recordati Rare Diseases
Wendy Kampman, MD, Chief Medical Affairs Officer, BioBridge

Case studies: Real-world evidence advancing patient care

Ali Almedhychy, MD, PhD, J&J MedTech/Abiomed
Brianna Cartwright, MS, Truveta Research

Panel: Genomic intelligence for precision and preventive medicine

Johnathan Lancaster, MD, PhD, President and Chief Scientific Officer, Truveta; former Senior Vice President and Head of Global Medical Affairs at Regeneron Pharmaceuticals
Daniel Roth, MD, Executive Vice President & Chief Operating Officer, Trinity Health
Jerry Lanchbury, PhD, Independent scientist
Laura H. Goetz, MD, MPH, FACS, Director, Precision Medicine, HonorHealth Research Institute and Research Professor, ASU John Shufeldt School of Medicine and Medical Engineering
Nicholas J. Schork, PhD, Research Director, Longevity, Prevention, and Inception, HonorHealth Research Institute, and Professor, ASU John Shufeldt School of Medicine and Medical Engineering

Breakout sessions

Hands-on lab: Building a study with Truveta Evidence

New population building template and demo	Emily Webber, PhD, Director of Research Enablement and Development, Truveta
Build your own population	Emily Webber, PhD, Director of Research Enablement and Development, Truveta
Building an end-to-end study	Sapna Prasad, PhD, Vice President, Truveta Research Insights Esther Kim, PhD, Senior Director, Truveta Evidence Services

Case studies: Advancing public health

Exploring biosimilar uptake	Esther Kim, PhD, Senior Director, Truveta Evidence Services
Early-stage cancer outcomes	Karen Gilbert Farrar, PhD, Senior Research Analyst, Truveta Research
Non-small cell lung cancer (NSCLC) insights	Truveta Research team
Exploring vaccination trends across the lifespan	Nina Masters, PhD, Senior Applied Research Scientist, Truveta Research

Health systems: Driving clinical and operational value with real-world data

Truveta Intelligence for health systems vision	Johnathan M. Lancaster, MD, PhD, President and Chief Scientific Officer, Truveta
Addressing unmet patient need: Boehringer Ingelheim	Lu Zhang, ScD, Senior Associate Director, Boehringer Ingelheim
Case study: Empowering clinicians with AI models trained with real-world data	Sophie Pinkard, Chief Product Officer, Knit Health

Speakers

Khaled Abdelgawward

Senior Director and Principal RWE Researcher

Bayer

Heather Rubino, PhD, MS

Head Safety Surveillance

Pfizer

Terry Myerson

CEO and co-founder

Truveta

Johnathan Lancaster, MD, PhD

President and Chief Scientific Officer; former Senior Vice President and Head of Global Medical Affairs at Regeneron Pharmaceuticals

Truveta

John Seeger, PharmD, DrPH, FISPE

SVP of Evidence Services; former VP for Epidemiology for RTI-HS and Chief Scientific Officer for Epidemiology at Optum

Truveta

Daniel Roth, MD

Executive Vice President & Chief Operating Officer

Trinity Health

Greg Gillum, RN

Director, Medical Affairs Impact and Data Enablement

Boehringer Ingelheim Pharmaceuticals, Inc.

Alessandro Albuquerque, MS MSc PhD

Chief Medical Officer and VP of Medical Affairs & Clinical Development

Recordati Rare Diseases

Michael R. Jaff, DO

Chief Medical Officer, Vice President, Clinical Affairs, Technology & Innovation, Peripheral Interventions

Boston Scientific

Jonathan Carlson, PhD

Vice President and Managing Director

Microsoft Research Health Futures

Nicholas Schork, PhD

Director, Longevity Research

HonorHealth

Laura Goetz, MD, MPH, FACS

Director, Precision Medicine Research

HonorHealth

Wendy Kampman, MD

Chief Medical Affairs Officer

BridgeBio

Jen Webster, MS

Vice President, RWD Activation

Pfizer

“Trusted real-world data has the potential to advance care, address health inequities, and accelerate science. It is an honor to bring together innovative industry leaders and renowned researchers across health systems, public health, and life science at Truveta Symposium this week. The collaborations established here have the potential to rapidly accelerate our shared mission of Saving Lives with Data.”

Terry Myerson

Chief Executive Officer & co-founder, Truveta

“We have an opportunity to democratize care by connecting leaders across healthcare to learn, collaborate, and dream together. Truveta Symposium enables us to join forces and accelerate progress in critical areas like cardiovascular, oncology, and rare diseases to advance care for everyone.”

Rod Hochman, MD

President & CEO, Providence; Truveta board chair

“From my earliest discussions with Truveta, I saw the unique opportunity for leaders across healthcare to come together with a shared mission. Truveta Symposium creates this opportunity for us to come together, explore fascinating research, and discuss the opportunities and challenges facing us today with much hope for the future.”

Michael Jaff, DO, FACC

Chief Medical Officer, Vice President, Clinical Affairs, Technology & Innovation, Peripheral Interventions, Boston Scientific

Terms and conditions

Registration is required, and at Truveta’s discretion, for attendance. Each registration is valid for one attendee only. By registering for and attending this event, you agree to the following terms:

- Truveta is committed to fostering an inclusive, respectful, and professional environment. You are expected to treat fellow attendees and event staff with courtesy and respect.
- Photos and recordings may be taken during the event.
- If you are not from an organization that is a Truveta customer, you may not record, reproduce, or distribute any event content without prior written permission from Truveta.
- Truveta may make changes to the schedule.
- If you are unable to attend or have any questions or concerns, please notify the Truveta team at symposium@truveta.com

Come join us in Seattle at Truveta Symposium 2026

Please fill out the form below to attend.

If you have questions or need assistance, email us at symposium@truveta.com

Terms & conditions

By attending, you consent to being photographed and recorded by Truveta for marketing purposes. Personal recording or sharing is prohibited unless authorized, and we ask all participants to remain respectful and professional.